AzTrials
AzTrials

BalanceDEPIENCT06682754

Detection of Balance in the Elderly Under the Influence of Stress

A study testing Stress in people with Balance, run by University of Alcala at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aging process involves physiological changes in organs and tissues that can evolve towards fragility and increased risk of falls. Falls, which can be one of the adverse results of frailty in older people, are the second leading cause of death worldwide. Read more about this study

Who is it for?
Ages 18 to 99 yearsHealthy volunteers can take part
Conditions the study is for
Balance
What is being tested?
Stress
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
27 Nov 2024to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Young adults (ages 18-39).
  • Older adults (≥65).
  • Voluntarily participate in the study.
  • Not meeting the exclusion criteria

Who cannot join

  • Any disease, injury, or previous trauma that contraindicates muscular exertion, balance exercises, and/or walking.
  • Any physical or mental illness that contraindicates exposure to stimuli generating emotional stress, such as severe depression or severe psychosis
  • Difficulties in understanding study information and providing informed consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Susana N Núñez, PhD. Associate Professor contact

0034918852524

susana.nunez@uah.es

Spain1 site, 1 recruiting
  • University of Alcalá

    Alcalá de Henares

    Susana N Núñez, PhD. Associate Professor, 0034918852524, susana.nunez@uah.es

    Recruiting

Other trials in Spain

About this study

Official title: Use of Balance Detection Devices for Elderly People Under the Influence of Stress (DEPIE)

The aging process involves physiological changes in organs and tissues that can evolve towards fragility and increased risk of falls. Falls, which can be one of the adverse results of frailty in older people, are the second leading cause of death worldwide. When an elderly person falls, it entails not only hospitalization, immobilization, and the consequent deterioration, but also usually causes fear of falling again, which can also lead to the onset of disability. The inherent aging process can be linked to the deterioration of postural control and balance, posing serious health problems. In falls in the elderly, both sensorimotor and cognitive functions are affected, the functioning of which is degraded to a greater extent by anxiety and stress. Nowadays, more extensive, and more precise research is needed in the study of the interactions between cognition, stress, and postural control in the context of postural instability and falls in older adults.

The purpose of the DEPIE Project is to detect whether neuromuscular changes that occur when exposed to stressful situations can affect the postural and motor control of the elderly.

Read more

To this end, all participants will undergo the same intervention. Firstly, they will all take a baseline cognitive and physical assessment. Afterwards, they will take the experimental session, which will consist of a baseline test and an experimental test. During the baseline test, participants will visualize International Affective Picture System (IAPS) images of low arousal and during the experimental test of high arousal. Finally, physical assessment tests will be repeated.

Young and older adults will be tested. Additionally, sub-analyses will be conducted within the elderly group differentiating the degree of cognitive impairment and functional dependence.

The primary outcome measures will be surface electromyography, pressures on the floor, activity on manipulation, and balance.

The secondary outcome measures will be heart rate variability, respiratory rate and the visual analogue scale on unease after visualisation of the images.

Conditions
Balance
Being tested
Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • StressOther

    All participants will perform a baseline test in which they will first be asked to visualize low-arousal IAPS images for three minutes while seated in a chair, and then get up, walk to a table with two bottles, transfer liquid from one bottle to the other, return to the starting chair and sit down again. Subsequently, they will perform an experimental test, where they will repeat the same movements as in the baseline test after visualizing high-arousal IAPS images for three minutes. In addition, IAPS images will continue to be projected in the background while participants perform the described motor tasks.

Study groups in NCT06682754
Study groupRoleWhat they receive
ExperimentalExperimentalAll participants will perform a baseline and an experimental test. There will be a group of young people and a group of older people, but all participants will perform the same intervention
Receives: Other: Stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressures on the floor

    They will be measured by a sensorised blanket that will give information on weight distribution and movement behaviour

    Measured: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test

  2. Triaxial accelerometry: acceleration and deceleration in object handling

    The maximum acceleration value during the handling activity of two bottles shall be measured with sensors installed on the bottles.

    Measured: It will be assessed while performing the bottle manipulation movement (during which liquid has to be transferred from one bottle to another), both during the baseline test and during the experimental test

  3. RMS value of the EMG signal

    The root mean square (RMS) value of the EMG signal reflects the level of muscle activation during activity.

    Measured: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test

  4. EMG: Synchronisation of activation between muscle groups

    It will assess in milliseconds the ability of the muscles to work in a synchronised manner.

    Measured: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test

  5. EMG: Activation ratio between upper and lower body muscles

    RMS ratio between different muscles

    Measured: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test

  6. EMG: Median Frequency (MDF)

    In the frequency domain, this median frequency of the EMG signal will be calculated.

    Measured: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test

  7. Balance

    It will be assessed by Timed Up and Go Test (TUG) and Functional Reach Test (FRT)

    Measured: Before the baseline test and after the experimental test

Secondary outcomes (3)
  1. Heart Rate Variability

    It will be explored for measures of autonomic nervous system activation

    Measured: It will be assessed during the visualization of IAPS images both during the baseline test and during the experimental test

  2. Respiratory Rate

    It will be explored for measures of autonomic nervous system activation

    Measured: It will be assessed during the visualization of IAPS images both during the baseline test and during the experimental test

  3. Analog Visual Scale

    It will assess the feeling of unease after performing the baseline test and the experimental test respectively. The scale consists of a line from 0 (= totally relaxed) to 10 (=the most uneasy or restless feeling you have ever felt), which participants have to mark according to their feelings at that moment. Higher scores will correspond to a greater sense of unease.

    Measured: Immediately after the baseline test and the experimental test respectively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Nov 2024
  2. Study start27 Nov 2024
  3. Primary completionJul 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06682754
Sponsor's protocol ID
CEIP/2023/5/110
Acronym
DEPIE
Status last verified
Aug 2025
First submitted
31 Oct 2024
Last updated
7 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Membership of GITES; Alarcos B, Diaz-Pulido B, Fernandez O, Fernandez-Guinea S, Garcia Herraiz A, Lendinez-Chica MDM, Martinez Muela J, Nunez-Nagy S, Perez-Martin Y, Rodriguez-Costa I, Rubio Gonzalez GM, Trapero-Asenjo S, Velasco JR. Detection of balance in the elderly under the influence of stress (DEPIE): A cross-sectional study protocol. PLoS One. 2026 Jan 27;21(1):e0341744. doi: 10.1371/journal.pone.0341744. eCollection 2026.

    PubMed 41592138

Questions about this trial

What is this clinical trial studying?

A study testing Stress in people with Balance, run by University of Alcala at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Susana N Núñez, PhD. Associate Professor (0034918852524, susana.nunez@uah.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressures on the floor (time frame: It will be assessed while performing the movements of getting up from the chair, walking, manipulating the bottles, returning to the chair and sitting down, both during the baseline test and during the experimental test). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06682754, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in